Baylon, Erwin B.

HRN: 09-69-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/03/2026
01/09/2026
IV DRIP
4.5g
Q6
Cap HR
Checking Final Appropriateness 
01/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/12/2026
01/18/2026
IVTT
2.25
Q6
Cap HR (renal Dose, Egfr: 38ml/min)
Checking Initial Appropriateness 
01/17/2026
MUPIROCIN 2%, 15G (TUBE)
01/17/2026
01/24/2026
TOPICAL
Apply On Affected Area
BID
CT Site Prophylaxis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: